# BayCom Corp: overview

BCML · Nasdaq · CIK 1730984 · [Financials](/sectors/financials.md)

Pages: [Overview](/companies/bcml.md) · [Financials](/companies/bcml/financials.md) · [Filings](/companies/bcml/filings.md) · [Insiders](/companies/bcml/insiders.md)

Latest reported revenue: [$885.0k](/filings/0001730984-23-000066.md) for Q1 FY2023, three months to 2023-03-31, from the 10-Q/A filed Jul 25, 2023 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001730984-23-000066).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.54](/filings/0001730984-25-000073.md) | not reported | [0.51](/filings/0001730984-26-000048.md) | [0.58](/filings/0001730984-26-000072.md) | [0.46](/filings/0001730984-25-000073.md) | not reported | [0.75](/filings/0001730984-26-000048.md) | [(0.64)](/filings/0001730984-26-000072.md) |
| Free cash flow | $k | [9,363 d](/filings/0001730984-25-000073.md) | [7,930 d](/filings/0001730984-26-000016.md) | [9,137](/filings/0001730984-26-000048.md) | [5,619 d](/filings/0001730984-26-000072.md) | [6,229 d](/filings/0001730984-25-000073.md) | [8,576 d](/filings/0001730984-26-000016.md) | [6,691](/filings/0001730984-26-000048.md) | [4,525 d](/filings/0001730984-26-000072.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.90](/filings/0001730984-24-000028.md) | [1.81](/filings/0001730984-25-000017.md) | [2.27](/filings/0001730984-26-000016.md) | [2.10](/filings/0001730984-26-000016.md) | [2.18](/filings/0001730984-26-000016.md) |
| Free cash flow | $m | [9.1](/filings/0001730984-24-000028.md) | [38.8](/filings/0001730984-25-000017.md) | [28.7](/filings/0001730984-26-000016.md) | [28.7](/filings/0001730984-26-000016.md) | [30.1](/filings/0001730984-26-000016.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bcml/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $33.4m | 1,015,978 |  | Reduced −2,644 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $30.5m | 926,776 |  | Added +78,633 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $26.5m | 805,051 |  | Added +82,860 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $21.0m | 637,001 |  | Added +19,144 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $15.2m | 462,691 |  | Reduced −77,009 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $8.8m | 267,980 |  | Added +16,575 |
| [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $8.7m | 265,773 |  | Reduced −102,737 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $7.1m | 213,187 |  | Added +23,503 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $5.6m | 169,860 |  | Added +65,568 |
| [HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC](/funds/1164833.md) | 2026-06-30 | $4.0m | 122,343 |  | Added +1,060 |

## Recent filings

[All 487 filings](/companies/bcml/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 20:23 ET | [8-K](/filings/0001730984-26-000081.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001730984-26-000081 |
| 2026-08-19 | 20:32 ET | [8-K](/filings/0001730984-26-000075.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001730984-26-000075 |
| 2026-08-10 | 20:15 ET | [10-Q](/filings/0001730984-26-000072.md) | Quarterly report, period 2026-06-30 | 0001730984-26-000072 |
| 2026-07-24 | 20:02 ET | [8-K](/filings/0001730984-26-000068.md) | 5.02 Departure or appointment of officers or directors | 0001730984-26-000068 |
| 2026-07-23 | 20:05 ET | [8-K](/filings/0001730984-26-000066.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001730984-26-000066 |
| 2026-07-22 | 20:17 ET | [8-K](/filings/0000927089-26-000133.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000927089-26-000133 |
| 2026-06-17 | 20:48 ET | [8-K](/filings/0001730984-26-000059.md) | 5.07 Shareholder vote results | 0001730984-26-000059 |
| 2026-05-22 | 15:09 ET | [8-K](/filings/0001730984-26-000054.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001730984-26-000054 |
| 2026-05-11 | 20:23 ET | [10-Q](/filings/0001730984-26-000048.md) | Quarterly report, period 2026-03-31 | 0001730984-26-000048 |
| 2026-04-29 | 21:02 ET | [DEF 14A](/filings/0001730984-26-000039.md) | Proxy statement, period 2026-06-16 | 0001730984-26-000039 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001730984-26-000016.md), filed Mar 16, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1730984
- Tickers: BCML
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: not reported
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.